Townsquare Capital LLC grew its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 3.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,519 shares of the company’s stock after purchasing an additional 130 shares during the period. Townsquare Capital LLC’s holdings in VanEck Pharmaceutical ETF were worth $334,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Optimum Investment Advisors purchased a new position in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $27,000. GPS Wealth Strategies Group LLC acquired a new stake in VanEck Pharmaceutical ETF in the second quarter valued at approximately $42,000. CWM LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth $55,000. International Assets Investment Management LLC acquired a new stake in VanEck Pharmaceutical ETF in the second quarter worth about $86,000. Finally, Comerica Bank boosted its stake in VanEck Pharmaceutical ETF by 39.4% in the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares in the last quarter.
VanEck Pharmaceutical ETF Trading Up 0.1 %
NASDAQ:PPH opened at $90.19 on Friday. The firm has a fifty day simple moving average of $91.52 and a 200-day simple moving average of $93.00. VanEck Pharmaceutical ETF has a 12 month low of $77.70 and a 12 month high of $99.51. The company has a market capitalization of $666.50 million, a P/E ratio of 21.04 and a beta of 0.72.
VanEck Pharmaceutical ETF Company Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Recommended Stories
- Five stocks we like better than VanEck Pharmaceutical ETF
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Bank Stocks – Best Bank Stocks to Invest In
- BlackRock Makes Waves With $12B Private Credit Acquisition
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
